Back
Morphic Holding Vs. Keros Therapeutics Industry Stock Comparison
Buy
70
MORF
Morphic Holding
Last Price:
32.42
Seasonality Move:
27.05%
Sell
20
KROS
Keros Therapeutics
Last Price:
54.03
Seasonality Move:
-7.87%
Buy
70
Morphic Holding (MORF)
is a Buy
Is Morphic Holding a Buy, Sell or Hold?
- The current Morphic Holding [MORF] share price is $30.23. The Score for MORF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MORF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $54.40. The Score for KROS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MORF Stock Price Chart
What is Morphic Holding's stock price today?
-
The Morphic Holding share price today is $30.23
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MORF is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $54.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
MORF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 54.25 | Buy |
| Chaikin Money Flow: | 108124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.78 - 29.62) | Buy |
| Bollinger Bands (100): | (28 - 35.74) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 40.71 | Sell |
| Chaikin Money Flow: | 82506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.1 - 59.56) | Sell |
| Bollinger Bands (100): | (50.3 - 65.58) | Sell |
MORF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.36 | Buy |
| 20-day SMA: | 28.66 | Buy |
| 50-day SMA: | 31.12 | Sell |
| 200-day SMA: | 33.39 | Sell |
| 8-day EMA: | 29.16 | Buy |
| 20-day EMA: | 29.22 | Buy |
| 50-day EMA: | 30.42 | Sell |
| 200-day EMA: | 33.54 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.3 | Sell |
| 20-day SMA: | 56.87 | Sell |
| 50-day SMA: | 61.47 | Sell |
| 200-day SMA: | 45.32 | Buy |
| 8-day EMA: | 55.49 | Sell |
| 20-day EMA: | 57.17 | Sell |
| 50-day EMA: | 58.61 | Sell |
| 200-day EMA: | 50.7 | Buy |
Morphic Holding Earnings Growth & MORF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.30 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.04 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
Morphic Holding Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||